According to Evolent Health's latest financial reports and stock price the company's current Operating Margin is -2.31%. At the end of 2023 the company had an Operating Margin of -10.31%.
Year | Operating Margin | Change |
---|---|---|
2023 | -10.31% | 124.47% |
2022 | -4.59% | 39.89% |
2021 | -3.28% | -90.82% |
2020 | -35.75% | -25.56% |
2019 | -48.02% | 456.12% |
2018 | -8.64% | -50.84% |
2017 | -17.57% | -81.2% |
2016 | -93.45% | -126.37% |
2015 | 354.35% | |
2013 | 78.03% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | 7.77% | -436.36% | ๐บ๐ธ USA |
![]() | 48.96% | -2,219.48% | ๐ญ๐ฐ Hong Kong |
![]() | 0.69% | -129.84% | ๐บ๐ธ USA |
![]() | 6.77% | -393.07% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.